SCHEMBL18049566

SCHEMBL18049566

[N-]=[N+]=NC1CCCCC1N=[N+]=[N-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16976716 1.00
SCHEMBL19876052 0.97
SCHEMBL13618927 0.97
SCHEMBL13696003 0.97
SCHEMBL29889012 0.97
SCHEMBL16095653 0.94
SCHEMBL14671356 0.94
SCHEMBL14504614 0.82 CA1 (0.33)
SCHEMBL13696603 0.82 CA1 (0.33)
SCHEMBL14075143 0.82 CA1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114105807-B Hydroxycyclohexanamide compound and preparation method and application thereof 暨南大学 2023-08-18 CN claimed
CN-114105807-A Hydroxycyclohexane diamide compound and preparation method and application thereof 暨南大学 2022-03-01 CN claimed
CN-114105807-B Hydroxycyclohexanamide compound and preparation method and application thereof 暨南大学 2023-08-18 CN disclosed
CN-114105807-A Hydroxycyclohexane diamide compound and preparation method and application thereof 暨南大学 2022-03-01 CN disclosed
EP-3267996-A1 PYRAZOLOPYRIMIDINE INHIBITORS OF IRAK4 ACTIVITY Merck Sharp & Dohme Corp. (US) 2018-01-17 EP disclosed
WO-2016144846-A1 PYRAZOLOPYRIMIDINE INHIBITORS OF IRAK4 ACTIVITY MERCK SHARP & DOHME CORP. (US) 2016-09-15 WO disclosed